Gamma Probe Devices Market Research Report 2024
Gamma Probe Devices Market Global Industry Analysis and Forecast (2024-2032) By Type (Standalone, Mobile), Application (Parathyroid surgical Treatment, Sentinel Lymph Node Mapping), End-User (Hospitals, Ambulatory Surgical Centers), And Region
Gamma Probe Devices Market Synopsis
Gamma Probe Devices Market Size Was Valued at USD 8690.43 Million in 2023 and is Projected to Reach USD 20341.18 Million by 2032, Growing at a CAGR of 9.91% From 2024-2032.
A gamma probe is a portable tool with a scintillation counter that is used during surgery after injecting a radioactive substance to find sentinel lymph nodes based on their radioactivity.Gamma probe devices are specific medical tools used for different purposes to help locate and detect gamma radiation released by radioactive materials. These tools have shown to be extremely useful in medical diagnosis and surgeries. The Primary use of gamma probe devices is in the field of nuclear medicine. They are utilized for identifying and quantifying gamma radiation released by radiopharmaceuticals, which are radioactive materials given to patients for diagnosis or treatment.
Gamma probe devices allow healthcare providers to observe and assess bodily functions by identifying and measuring gamma radiation levels. This data helps identify and treat different illnesses like cancer, heart disease, and neurological conditions.Gamma probe devices are especially helpful in locating sentinel lymph nodes during surgical procedures. These sentinel lymph nodes are typically the initial lymph nodes that cancer cells are prone to spread to from the original tumors. With the use of a gamma probe instrument, surgeons can identify and eliminate those particular lymph nodes, making surgical procedures more focused and accurate.Gamma probe devices are utilized in the field of radiotherapy. They assist in guaranteeing precise placement and administration of radiation treatment by confirming the existence and strength of gamma radiation emitted from the treatment zone. This live monitoring enables healthcare providers to modify and improve treatment settings, boosting the efficiency of radiotherapy and reducing potential adverse reactions.
Gamma probe devices are used for environmental monitoring to evaluate and measure radioactive contamination in the air, soil, and water, in addition to their medical uses. These gadgets help in detecting possible origins of radiation and play a role in initiatives focused on radiation safety and environmental preservation.
Top Active Players Involved Are:
“Dilon Technologies (USA), Devicor Medical Products (USA), Ziteo Medical (USA), Hologic (USA), Johnson & Johnson (USA), OncoVision (Spain), Cigna (USA), Intramedical Imaging (USA), Isotopia Molecular Imaging (Israel), Eckert & Ziegler (Germany), Capintec (USA), Biodex Medical Systems (USA), Digirad (USA), Sentinella (France), Iba Dosimetry (Germany), Care Wise Medical Products (USA), Eczacibasi-Monrol Nuclear Products (Turkey), Medtronic (USA), Thermo Fisher Scientific (USA), Tracerco (UK), NorthStar Medical Radioisotopes (USA), Polatom (Poland), NTP Radioisotopes (South Africa), Mediso Medical Imaging Systems (Hungary), Fukuda Denshi (Japan) and Other Active Players.”
Gamma Probe Devices Market Trend Analysis
Surging Breast Cancer Cases
- Breast cancer is frequently detected in women as one of the most common cancer diagnoses. There, has been a concerning increase in the global occurrence of breast cancer. This has resulted in a growing need for advanced diagnostic and therapeutic methods to help with early identification and successful treatment of the illness.
- Gamma probe devices are essential for the diagnosis and treatment of breast cancer. Healthcare professionals utilize these devices to identify and quantify gamma radiation from radioactive tracers injected into the body. Gamma probe devices are utilized in breast cancer for locating tumors, identifying sentinel lymph nodes, and assessing the efficacy of radiation therapy.
- Changes in lifestyle and environmental factors are key factors contributing to the increase in breast cancer diagnoses. Unhealthy eating habits, lack of physical activity, and contact with environmental toxins are among the main factors contributing to the development of cancer. Genetic predisposition, gender, and age are among the other factors that play a role in the increase in breast cancer incidence.
- The significance of early detection of breast cancer cannot be emphasized enough. It is advised for women who are 40 years old and older to receive regular mammograms and breast examinations to detect any issues at an early stage. Gamma probe devices, in addition to other imaging technologies, are utilized to aid in the early identification of cancer, enabling medical professionals to start treatment before the cancer spreads.
- The market for gamma probe devices is projected to keep expanding to meet the increasing demand. The rise in breast cancer cases, along with technological advancements, is fueling the creation of more sophisticated and effective gamma probe tools. These devices are anticipated to enhance the precision and responsiveness of breast cancer tests, resulting in timelier and more efficient therapies.
Opportunity
Product Development of Gamma Probe Devices
- The development of gamma probe devices for products represents a substantial potential in the market for gamma probe devices. This change comes from the ongoing progress and developments in technology, to improve the performance and abilities of these devices.
- Enhancing sensitivity and accuracy is a crucial element of product development. Improvements in detector technology and signal processing algorithms have allowed gamma probe devices to offer more accurate and dependable readings. This improved precision enables enhanced identification and pinpointing of cancerous tissues, resulting in superior treatment preparation and better patient results. Moreover, increased sensitivity guarantees the identification of even minute amounts of radioactive tracers, thus enhancing diagnostic precision.
- Another chance exists in making gamma probe devices smaller and easier to carry. With advancements in technology, gamma probe devices are getting smaller, more compact, and simpler to manage. Portable devices provide flexibility and convenience in different clinical environments, allowing for effective use during surgeries, in outpatient facilities, or even in distant locations. This advancement creates new opportunities to extend the use of gamma probe devices beyond typical hospital environments, ultimately reaching a broader patient demographic.
- Incorporation of additional technologies can also contribute to the advancement of gamma probe devices. The combination of gamma probe devices with imaging techniques like PET or MRI enables both anatomical and functional imaging. This merging results in a more thorough understanding of the illness, helping to pinpoint tumors accurately and enhance treatment preparation.
- Software progress is essential in the development of products. Advanced imaging software and data analysis algorithms make it easier to interpret and visualize gamma probe data, improving the diagnostic potential of these devices. Surgeons are aided in procedures by real-time image guidance and 3D mapping, enhancing surgical accuracy and minimizing the chances of leaving parts of the tumor behind.
Gamma Probe Devices Market Segment Analysis:
The Gamma Probe Devices market is segmented on the basis of Type, Application, and End-User.
By Type, Mobile Segment Is Expected to Dominate the Market During the Forecast Period
- The mobile segment is the leading choice in the gamma probe devices market among healthcare professionals, resulting in its dominance. mobile gamma probe devices provide important benefits in terms of mobility and convenience. These devices are light, small, and made for convenient portability, enabling healthcare providers to utilize them in different clinical environments.
- Portable gamma probe devices eliminate the requirement for patients to be transported to specialized imaging rooms, allowing for immediate and live readings. This flexibility improves the efficiency of work processes and the comfort of patients, especially in environments like operating rooms, outpatient clinics, and emergency departments.
- The mobile sector focuses on meeting the need for point-of-care testing. In critical situations, immediate and accurate measurements are needed due to the increasing focus on early diagnosis and intervention. Mobile gamma probe devices offer immediate results, enabling doctors to make quick decisions and direct their actions accordingly. They provide instant feedback without the wait time seen with traditional imaging techniques.
- Mobile gamma probe devices have seen great enhancements in capabilities due to technological advancements. These gadgets now include advanced imaging software, state-of-the-art detectors, and signal processing algorithms, guaranteeing high sensitivity and accurate pinpointing of radioactive tracers. Manufacturers are constantly creating new features and functionalities like wireless connectivity and user-friendly interfaces to improve the attractiveness and functionality of mobile gamma probe devices.
- The cost efficiency of portable gamma probe equipment is another contributing factor. These devices are frequently less expensive than larger, immobile imaging systems, making them an appealing choice for healthcare facilities with restricted budgets. Mobile devices provide a cost-effective method to extend the reach of gamma probe technology, especially in areas with limited resources or infrastructure.
By Application, Parathyroid Surgical Treatment Segment Held the Largest Share In 2023
- Gamma probe devices in parathyroid surgical treatment, surgery for the parathyroid glands is a widely recognized and frequently performed procedure, with gamma probe instruments being essential for its effectiveness. Parathyroid surgery consists of finding and taking out malfunctioning parathyroid glands that cause excessive production of parathyroid hormone (PTH).
- Gamma probe devices help surgeons locate these glands with precision by identifying and measuring the radioactivity emitted from injected radiopharmaceuticals. This accurate positioning aids in guaranteeing the thorough extraction of impacted glands, leading to effective treatment results.
- Gamma probe devices during parathyroid surgery result in enhanced patient outcomes and decreased surgical complications. These devices help surgeons pinpoint abnormal parathyroid glands, allowing them to reduce the need for extensive surgery and prevent harm to nearby healthy tissues. Distinguishing affected parathyroid glands from neighboring structures like thyroid glands, lymph nodes, or blood vessels minimizes the chances of accidental harm, protects essential tissues, and improves surgical accuracy and precision.
- Gamma probe devices help decrease surgical durations and shorten patient recovery time. Surgeons can carry out parathyroid surgeries more effectively with the help of real-time guidance from these devices, resulting in decreased time spent in surgery. This results in reduced anesthesia time for patients, while also aiding in more efficient use of resources in healthcare settings. Moreover, the surgery is less invasive because of precise localization, leading to faster patient recovery, minimal scarring, and shorter hospital stays.
Gamma Probe Devices Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast Period
- North America is predicted to lead the market for gamma probe devices because of various critical factors that support its top position in the sector. It boasts a strong healthcare infrastructure that includes state-of-the-art medical facilities, research institutions, and a heavy emphasis on technological progress.
- The area is recognized for its elevated healthcare spending and strong reimbursement regulations, creating advantageous circumstances for the acceptance of cutting-edge medical tools such as gamma probe devices. The popularity of these devices in diagnostic and surgical procedures is boosted by the existence of well-known medical facilities and experienced healthcare professionals.
- North America, particularly with a high occurrence of breast cancer, melanoma, and other types of malignancies. Gamma probe devices are crucial in cancer care as they help in accurately pinpointing and locating sentinel lymph nodes, which are essential for accurate staging and gauging the severity of the disease. The utilization of gamma probe devices during cancer surgeries like breast cancer lumpectomies and melanoma excisions is now common, leading to North America's strong presence in the market.
- These progressions involve the integration of cutting-edge detector materials, software algorithms, and imaging modalities, improving the functionalities of gamma probe devices. Cutting-edge technology, key industry players, and collaborations between research institutions and manufacturers in North America drive innovation and speed up market growth.
- The region's dominance is bolstered by favorable regulatory frameworks and streamlined approval processes for medical devices in North America. Organizations such as the FDA and Health Canada uphold rigorous safety and efficacy standards, inspiring trust. Hence, in this way North America is Expected to Dominate the Gamma Probe Devices Market.
- As of January 1, 2023, there were around 4.06 million women in the U.S. who had been diagnosed with breast cancer and had survived. Breast cancer is the most common type of cancer among women in the U.S., however, cancer of the lung and bronchus accounts for the most cancer-related deaths among women.
Gamma Probe Devices Market Active Players
- Dilon Technologies (USA)
- Devicor Medical Products (USA)
- Ziteo Medical (USA)
- Hologic (USA)
- Johnson & Johnson (USA)
- Oncovision (Spain)
- Cigna (USA)
- Intramedical Imaging (USA)
- Isotopia Molecular Imaging (Israel)
- Eckert & Ziegler (Germany)
- Capitec (USA)
- Biodex Medical Systems (USA)
- Digirad (USA)
- Sentinella (France)
- Iba Dosimetry (Germany)
- Care Wise Medical Products (USA)
- Eczacibasi-Monrol Nuclear Products (Turkey)
- Medtronic (USA)
- Thermo Fisher Scientific (USA)
- Tracerco (UK)
- Northstar Medical Radioisotopes (USA)
- Polatom (Poland)
- NTP Radioisotopes (South Africa)
- Mediso Medical Imaging Systems (Hungary)
- Fukuda Denshi (Japan) and Other Active Players
Key Industry Developments in the Gamma Probe Devices Market:
- In June 2024, The European Union financed the delivery of new equipment for the Oncological Institute of Moldova, the EU Delegation to Moldova. The International Organisation for Migration in Moldova facilitated the delivery of the equipment in May this year, as part of a project funded by the European Commission’s Service for Foreign Policy Instruments. The equipment – a CENNA-500W Gamma Probing System – will allow the implementation of a new diagnostic method in Moldova.
- In March 2024, Lightpoint Surgical Limited announced the first bladder cancer sentinel lymph node procedure with SENSEI®, Telix’s miniature robotic-assisted gamma probe used to detect radiation in patients and guide surgery. The patient was operated on at Hospital del Mar in Barcelona, Spain. The miniature size and proprietary features make the technology ideal for tight surgical spaces such as around the bladder.
|
Gamma Probe Devices Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 8690.43 Bn. |
|
Forecast Period 2024-32 CAGR: |
9.91 % |
Market Size in 2032: |
USD 20341.18 Bn. |
|
Segments Covered: |
By Type |
|
|
|
By Application |
|
||
|
By End-User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Gamma Probe Devices Market by By Type
4.1 Gamma Probe Devices Market Snapshot and Growth Engine
4.2 Gamma Probe Devices Market Overview
4.3 Standalone
4.3.1 Introduction and Market Overview
4.3.2 Historic and
Frequently Asked Questions
What would be the forecast period in the Gamma Probe Devices Market research report?
The forecast period in the Gamma Probe Devices Market research report is 2024-2032.
Who are the key players in the Gamma Probe Devices Market?
Dilon Technologies (USA), Devicor Medical Products (USA), Ziteo Medical (USA), Hologic (USA), Johnson & Johnson (USA), OncoVision (Spain), Cigna (USA), Intramedical Imaging (USA), Isotopia Molecular Imaging (Israel), Eckert & Ziegler (Germany), Capintec (USA), Biodex Medical Systems (USA), Digirad (USA), Sentinella (France), Iba Dosimetry (Germany), Care Wise Medical Products (USA), Eczacibasi-Monrol Nuclear Products (Turkey), Medtronic (USA), Thermo Fisher Scientific (USA), Tracerco (UK), NorthStar Medical Radioisotopes (USA), Polatom (Poland), NTP Radioisotopes (South Africa), Mediso Medical Imaging Systems (Hungary), Fukuda Denshi (Japan) and Other Active Players.
What are the segments of the Gamma Probe Devices Market?
The Gamma Probe Devices Market is segmented into Type, Application, End-User, and region. By Type, the market is categorized into Standalone and mobile. By Application, the market is categorized into Parathyroid surgical Treatment and sentinel Lymph Node Mapping. By End-User, the market is categorized into Hospitals and ambulatory Surgical Centers. By region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Bulgaria; The Czech Republic; Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; Netherlands; Italy; Russia; Spain; Rest of Western Europe), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).
What is the Gamma Probe Devices Market?
A gamma probe is a portable tool with a scintillation counter that is used during surgery after injecting a radioactive substance to find sentinel lymph nodes based on their radioactivity.
How big is the Gamma Probe Devices Market?
Gamma Probe Devices Market Size Was Valued at USD 8690.43 Million in 2023 and is Projected to Reach USD 20341.18 Million by 2032, Growing at a CAGR of 9.91% From 2024-2032.
